Ultrasound-unenhanced CT fusion for the follow-up of ureteral stones
07:00Eyal Bercovich, Haifa / IL
3
F-18-FDG-PET/CT imaging of COVID-19 in a prospective clinical study
07:00Sandor Czibor, Budapest / HU
4
Validation of the PSMA-RADS 1.0 system for the structured interpretation of F18-PSMA-PET/CT scans in diagnosing prostate cancer
07:00Thomas Geyer, Munich / DE
5
Total body PET/CT vs conventional PET/CT in lymph node staging of non-small cell lung cancer
07:00Lorenzo Nardo, Sacramento / US
6
Changes in tumour lesion glycolysis are associated with clinical endpoints in patients with advanced NSCLC receiving immune checkpoint inhibitor therapy: a prospective single-centre study
07:00Daria Kifjak, Vienna / AT
7
Pre- to post-treatment evolution of PET/CT parameters in CAR-T cell treatment of lymphoma
07:00Michael Winkelmann, Munich / DE
8
Hybrid photoacoustic-ultrasound breast tomography: first patient results